IL237741A0 - Magnesium hydroxide carbonate as a carrier in the preparation of preparations that include an active substance - Google Patents

Magnesium hydroxide carbonate as a carrier in the preparation of preparations that include an active substance

Info

Publication number
IL237741A0
IL237741A0 IL237741A IL23774115A IL237741A0 IL 237741 A0 IL237741 A0 IL 237741A0 IL 237741 A IL237741 A IL 237741A IL 23774115 A IL23774115 A IL 23774115A IL 237741 A0 IL237741 A0 IL 237741A0
Authority
IL
Israel
Prior art keywords
active ingredient
carrier material
magnesium hydroxide
containing preparations
hydroxide carbonate
Prior art date
Application number
IL237741A
Other languages
English (en)
Hebrew (he)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of IL237741A0 publication Critical patent/IL237741A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL237741A 2012-09-18 2015-03-15 Magnesium hydroxide carbonate as a carrier in the preparation of preparations that include an active substance IL237741A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12006551 2012-09-18
EP13000730 2013-02-13
PCT/EP2013/002490 WO2014044342A1 (de) 2012-09-18 2013-08-19 Magnesiumhydroxidcarbonat als trägermaterial in wirkstoffhaltigen zubereitungen

Publications (1)

Publication Number Publication Date
IL237741A0 true IL237741A0 (en) 2015-05-31

Family

ID=49084960

Family Applications (1)

Application Number Title Priority Date Filing Date
IL237741A IL237741A0 (en) 2012-09-18 2015-03-15 Magnesium hydroxide carbonate as a carrier in the preparation of preparations that include an active substance

Country Status (9)

Country Link
US (1) US20150273062A1 (enExample)
EP (1) EP2897645A1 (enExample)
JP (1) JP6244363B2 (enExample)
KR (1) KR20150058427A (enExample)
CN (1) CN104640569A (enExample)
BR (1) BR112015005621A2 (enExample)
CA (1) CA2885105A1 (enExample)
IL (1) IL237741A0 (enExample)
WO (1) WO2014044342A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112812194A (zh) 2014-12-11 2021-05-18 信越化学工业株式会社 制备烷基纤维素的方法
US10723807B2 (en) 2017-03-31 2020-07-28 Shin-Etsu Chemical Co., Ltd. Method for producing hydroxyalkyl alkyl cellulose
JP6423481B1 (ja) * 2017-04-28 2018-11-14 神島化学工業株式会社 炭酸マグネシウム
WO2020176028A1 (en) * 2019-02-25 2020-09-03 Disruptive Materials Ab Particulate amorphous mesoporous magnesium carbonate material
JP7093812B2 (ja) * 2019-06-27 2022-06-30 Ｄｏｗａエレクトロニクス株式会社 銀粉およびその製造方法
KR102483759B1 (ko) * 2022-01-18 2022-12-30 박민규 필러 조성물의 제조 방법
CN116515343B (zh) * 2023-05-24 2024-08-30 江西广源新材料有限公司 一种视黄酸/水菱镁复合粉体及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3242353A1 (de) * 1982-11-16 1984-05-30 Hoechst Ag, 6230 Frankfurt Lagerstabile, die wirkstoffe pyrazophos und captafol enthaltende mittel
JPH0768121B2 (ja) * 1987-07-21 1995-07-26 信越化学工業株式会社 固形薬剤のコ−ティング方法
DE3819926A1 (de) * 1988-06-11 1989-12-14 Gruenau Gmbh Chem Fab Verfahren zur verbesserung des fliessverhaltens von zum verklumpen neigenden pulvermischungen
JPH07114946B2 (ja) * 1988-10-24 1995-12-13 株式会社奈良機械製作所 難溶性物質の処理方法
JPH04228420A (ja) * 1990-06-04 1992-08-18 Tokuyama Soda Co Ltd 塩基性炭酸マグネシウム及びその製造方法
JPH04369375A (ja) * 1991-06-17 1992-12-22 Matsushita Refrig Co Ltd 冷蔵庫
JPH05194275A (ja) * 1991-09-03 1993-08-03 Takeda Chem Ind Ltd 製剤用組成物、固形製剤および薬物の防臭方法
JP3005883B2 (ja) 1992-12-28 2000-02-07 富士化学工業株式会社 リン酸水素カルシウムの製造方法およびそれを用いた賦形薬
JP2700141B2 (ja) 1993-09-17 1998-01-19 富士化学工業株式会社 リン酸水素カルシウム及びその製法並びにそれを用いた賦形剤
US20020072602A1 (en) * 2000-07-07 2002-06-13 Claude Singer Micronized mirtazapine
JP3910495B2 (ja) * 2002-02-13 2007-04-25 日鉄鉱業株式会社 塩基性炭酸マグネシウム及びその製造方法、並びに該塩基性炭酸マグネシウムを含有する組成物又は構造体
JP3910555B2 (ja) * 2002-09-17 2007-04-25 日鉄鉱業株式会社 中空担体及び機能性粒子、並びにそれらの製造方法
JP4274963B2 (ja) * 2004-02-04 2009-06-10 株式会社日本色材工業研究所 固形粉末化粧料
IS7724A (is) * 2005-03-02 2006-09-03 Actavis Group Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
ES2497574T3 (es) * 2010-02-03 2014-09-23 Merck Patent Gmbh Hidróxido carbonato de magnesio directamente compresible
WO2011095669A1 (en) 2010-02-04 2011-08-11 Nokia Corporation Adjusting channel access parameters due to traffic load
FR2967913A1 (fr) * 2010-11-29 2012-06-01 Vetalis Composition galenique adaptee a l'administration a un animal non-humain, utilisations de celle-ci et methodes associees

Also Published As

Publication number Publication date
KR20150058427A (ko) 2015-05-28
CN104640569A (zh) 2015-05-20
JP6244363B2 (ja) 2017-12-06
WO2014044342A8 (de) 2015-02-12
EP2897645A1 (de) 2015-07-29
WO2014044342A1 (de) 2014-03-27
BR112015005621A2 (pt) 2017-07-04
JP2015530393A (ja) 2015-10-15
CA2885105A1 (en) 2014-03-27
US20150273062A1 (en) 2015-10-01

Similar Documents

Publication Publication Date Title
TWI561171B (en) Active compound combinations
SG11201406395VA (en) Cosmetic composition carrier comprising foams
HUE039001T2 (hu) Bõr-kontakt anyag
PL3028948T3 (pl) Próżniowe pakowanie typu skin
IL207624A0 (en) T-slot cutter
HUE049541T2 (hu) Kis cella aktiválási eljárása
HUE058783T2 (hu) Egy amfipatikus peptid
SG11201500292SA (en) Pill crushing system
IL237741A0 (en) Magnesium hydroxide carbonate as a carrier in the preparation of preparations that include an active substance
IL234571A (en) Implant containing biologically active substance
PL2895254T3 (pl) Zbiorniczek do przechowywania substancji czynnej
EP2672989A4 (en) IMMUNOGENIC COMPOSITION WITH ALPHA-HEMOLYSIN OLIGOPEPTIDES
PL2716421T3 (pl) Nóż
SG11201501122WA (en) Solid pharmaceutical preparation containing levothyroxine
AU347138S (en) Cup for pill crushing
PL2703133T3 (pl) Nóż
EP2883492A4 (en) PERIMETER
PL2644189T4 (pl) Stabilne formulacje bortezomibu
AU347137S (en) Cup for pill crushing
EP2843042A4 (en) CELL PREPARATION CONTAINING AN ENGAGED MYOCARDIAL CELL
PT2864328T (pt) Compostos farmaceuticamente ativos
EP2870962A4 (en) TRANSDERMAL ABSORBABLE PREPARATION WITH ROTIGOTINE
EP2870883A4 (en) COMPOSITION WITH BIOLOGICAL ACTIVE SUBSTANCE
PL2839829T3 (pl) Tabletka o przedłużonym uwalnianiu zawierająca lewodropropizynę i sposób jej wytwarzania
EP2819223A4 (en) POSITIVE ACTIVE ELECTRODE MATERIAL